NovoRapid FlexPen 100 U/mL contains insulin aspart, a rapid-acting insulin analogue used for blood glucose management in people with diabetes when prescribed by a qualified healthcare professional.
The FlexPen delivery system provides a convenient and reliable method for insulin administration. Dosage, timing, and treatment adjustments should always be determined by a healthcare provider based on individual treatment requirements.
Key Benefits
- Contains insulin aspart rapid-acting insulin
- Convenient pre-filled FlexPen delivery system
- Designed for accurate insulin administration
- Manufactured to pharmaceutical quality standards
- Supports prescribed diabetes management plans
Reviews
There are no reviews yet.